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Summary 
The idea that stem cells oscillate between a state of activity and dormancy, thereby giving rise 
to differentiating progeny either randomly or in orderly clonal succession, has important impli- 
cations for understanding normal hematopoiesis and blood cell dyscrasias.  The degree of clonal 
stability  in  individuals  also  has  practical  implications  for  the  evaluation  of clonal  lympho- 
myeloproliferative diseases.  To  evaluate  the  clonality pattern  of the  different types of blood 
cells as a function of time we have validated the applicability, sensitivity, and reproducibility of 
a thermostable ligase reaction to detect transcripts of the G6PD allele on the active X-chromo- 
some in normal heterozygous females. While the ratio of the two X-chromosome-derived al- 
lelic transcripts varied widely among hemopoietic and nonhemopoietic tissues  in a given indi- 
vidual, this allelic ratio was virtually identical in all types of mature myeloid and lymphoid cells. 
Longitudinal studies indicated constancy of the G6PD allelic  ratio in blood cells  over a 912-d 
period of observation in healthy females. The individual variability observed in this allelic  ratio 
suggests that the progeny of a relatively small number of original embryonic hemopoietic stem 
cells,  approximately eight, contribute to the sustained production of all types of blood cells in 
healthy individuals. 
O 
ne  view  of hematopoietic  stem  cell  differentiation 
holds  that all  of the stem cells  in  an individual  con- 
tribute  continuously to hematopoiesis throughout  life (1). 
An  alternate  theory of clonal succession  suggests that  he- 
matopoiesis is maintained by an active subset of stem cells 
with dormant stem cells in reserve. As the active clones are 
exhausted, possibly through terminal differentiation, a pro- 
portion  of the  dormant  reserve  cells  becomes  active  to 
maintain  hematopoiesis  until  they  also  become  depleted, 
and the process repeats itself. 
The serial evaluation of hematopoiesis presented here is 
based on  a  clonal assay  identifying the  active X  chromo- 
some. Early in  development, one X  chromosome in  each 
primordial  cells  of female embryo is  inactivated  (2).  The 
molecular  events  leading  to  X-chromosomal  inactivation 
are  not  fully  understood,  but  it  is  known  that  some 
X-chromosomal  genes  escape  the  inactivation  process 
which is initiated by the Xi-specific transcripts (XIST) gene 
in the inactivation center (2), The polymorphism of consis- 
tently  inactivated  genes,  such  as  the  glucose-6-phosphate 
dehydrogenase  gene  (G6PD), 1 can  be  used  for  clonality 
studies.  The  clonality of functional stern cells  can thus be 
determined by transcriptional analysis  of the active X  chro- 
mosome in  females  heterozygous  for  an  X  chromosome 
exonic polymorphism. A  common C/T  polymorphism is 
present in  G6PD in exon  11  at position  1311  (3,  4).  This 
polymorphism does not change the peptide sequence and is 
therefore silent. The G6PD polymorphism is present in all 
races and ethnic groups, suggesting an ancient origin of this 
mutation. 
We have developed a method for detection of this poly- 
morphism  by  a  ligase  detection  reaction  (LDR)  that  is 
based on the  ability of a  thermostable ligase to  covalently 
bind with DNA oligonucleotides only when they are per- 
fectly complementary to  the  target DNA  in  the  ligation 
region (5-8). The polymorphism is detected in this PCR- 
based assay by the ligation product of allele-specific oligo- 
1Abbreviations used in this paper: G6PD, glucose-6-phosphate  dehydroge- 
nase gene; LDR, ligase detection reaction. 
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the 5' common radiolabeled oligonucleotide. This sensitive 
assay  was  used to  examine the active G6PD alleles in the 
different populations of blood cells in females heterozygous 
for  this  polymorphism.  Our  earlier studies indicated that 
the  usage  ratio  for  the  two  X-chromosome alleles varies 
widely in samples of different tissues in a heterozygous fe- 
male, while the different types of hematopoietic cells may 
share the same allelic ratio (5, 6). 
In the present study serial determinations of the C/T al- 
lele ratios of the different lineages of peripheral blood cells 
were made to examine the issue of relative clonal stability 
of hematopoietic cells in normal females.  These data  also 
allowed estimation of the number of founder hematopoie- 
tic  stem  cells in females after embryonic X-chromosomal 
inactivation. 
Materials and Methods 
Study  Group, Isolation of Blood Cells and  RNA  Preparation. 
Peripheral  blood samples were collected  from healthy volunteers 
after  obtaining informed consent. EDTA anti-coagulated blood 
(5 ml) was obtained for preparation of myeloid cells and heparin- 
ized  blood  (5  ml)  was  used for  mononuclear cell  preparation. 
Myeloid populations (granulocytes,  reticulocytes,  platelets) were 
separated by differential centrifugation, isopyknic density gradient 
separation,  and dextran sedimentation using standard  protocols 
(9). Mononuclear cells were purified further by immunofluores- 
cence-directed sorting of the nonadherent mononuclear popula- 
tion into CD3 + T lymphocytes,  CD19 § B lymphocytes,  CD56 + 
NK cells and CD14 + monocytes using a FACS  |  Star plus (Bec- 
ton Dickinson and Co., San Jose,  CA). Reticulocytes were lysed 
in NH4HCO3/NH4CI buffer,  followed by acid precipitation of 
RNA (10) that was further purified by guanidium thiocyanate ex- 
traction. Leukocyte and platelet  RNAs were  prepared  by acid 
guanidium thiocyanate extraction using standard protocols (11). 
Transcriptional Analysis of the Active X-Chromosome.  The  LDR 
analysis of G6PD transcripts was performed using genornic DNA 
or cDNA templates  prepared by the  reverse  transcriptase  PCR. 
from total cellular RNA (12). The initial analysis of samples ob- 
tained over the first 360 d used previously described experimental 
conditions (5, 6). When additional analyses of clonality encom- 
passing  the  entire  912-d  interval were  performed  at  580  and 
912 d, repeat analyses of stored R.NA aliquots of the day 0 sample 
were included. These analyses used the GeneAmp PCR System 
9600  (Perkin-Elmer Corp.,  Norwalk,  CT)  and modification of 
the  PCR  conditions for  amplification of cDNA  fragments  to 
include denaturation at 94~  for 5 rain before the first cycle, then 
primer annealing  at 60~  for 30 s, extension at 72~  for 30 s, and 
denaturation for 30 s at 94~  After completion of 30 cycles the 
sample was subjected to a final 6-rain incubation at 72~  After 
the  first  amplification  with  external primers,  1  btl  of the  first 
amplification reaction mixture was used  as the template for the 
second round of amplification with an identical PCI< program. 
To  evaluate  the  amplification products,  10  I*l  of the  reaction 
mixture was withdrawn and the sample electrophoresed  in a 1% 
agarose gel. 
Three oligonucleotides were used for the LDR.: a 23-mer with 
a 3'-G-ending  specific for the C allele, a 25-mer with 3'-A-end- 
ing for the T  allele, and a 21-mer labeled  at the 5'  end by T4 
kinase  as  an adjacent oligonucleotide ligating with both  allele- 
specific  oligonucleotides. The  reaction conditions allowed de- 
tection of both alleles using either PCR amplified genomic DNA 
or cDNA as the templates.  The T  allele was detected by a 46- 
nucleotide fusion product and the  C  allele by a 44-nucleotide 
product, as described  (5,  6).  The radiolabeled  reaction products 
were separated  on 15% polyacrylamide gel containing 7 M  urea 
and identified by autoradiography.  The ratio  of C  and T  alleles 
was determined by using a Phosphorlmager (Molecular  Dynam- 
ics, Sunnyvale, CA). 
Study Design and Statistical Analysis.  Relative stability  of the 
C/T ratios was determined by examining the differences between 
two time intervals  (e.g.,  day  180 minus day 0)  using the  (one- 
sample) Wilcoxon signed rank test.  Separate  analyses were per- 
formed for isolated samples of each cell type. Since the C/T ratio 
proved to be virtually identical for the different  types  of blood 
cells in each  subject,  the primary analysis provided the mean of 
the differences between the cell types for each subject. The mea- 
surements for each of the different blood cell types in a given in- 
dividual at a given time were used for calculation of the standard 
error of measurement. 
For estimation of the number of embryonic stem cells gener- 
ated  after  X-chromosomal inactivation, the  probability of each 
C/T heterozygous  cell choosing to express the C allelic transcript 
was assumed to be random (1  in 2), and the proportion of cells 
expressing the C allele was assumed to be stable after X-chromo- 
some inactivation  given that our experimental data indicated con- 
stancy of the proportion of C allelic cells within the reticulocyte, 
platelet,  granulocyte, and mononuclear cell populations over the 
period of observation. If K is used to denote the number of stem 
cells present at the time of X-chromosome inactivation, the per- 
centage of active C allelic cells at the time of X-chromosome in- 
activation would have a mean 1/2 and variance  1/4K.  It is rea- 
sonable to assume that the percentage of active C allelic cells from 
a heterozygous  subject is approximately normally distributed with 
mean 1/2 and variance "r  2 =  1/4K. This variance formula "r  2 =  1/4K 
was  used  to  estimate  the  number of stem  cells at  the  time of 
X-chromosome inactivation. Allowing for possible minor bias of 
the allele detection technique and measurement errors, the mea- 
sured  percentage of C  allelic cells in a components-of-variance 
model (13, 14)  could be used  to  obtain an estimate  and confi- 
dence intervals for "r  2, and to determine the value for K. The test 
for changes in the proportion of C  allele usage over time using 
Wilks' Lambda is as described by P,  ao (13), analysis of variance by 
the analysis of variance program (13), components of the variance 
model described by Graybill (15) and signed rank test by standard 
methods (16). 
Results 
Relative Frequency of G6PD  C/T  Heterozygosity.  Ge- 
nomic DNA  samples  from  117  female  individuals of di- 
verse ethnic backgrounds were  analyzed to  determine the 
heterozygote frequency for the G6PD C/T polymorphism. 
49 were  healthy volunteers. The remainder were  patients 
and  their  relatives  who  were  examined  for  possible  ac- 
quired or congenital hematological disorders. In this ethni- 
cally diverse group of individuals, 91  had only the C  allele, 
5  had the  T  allele, and 21  had both alleles. Heterozygous 
individuals were found in all of the different ethnic groups 
examined:  Caucasian,  African-American, Ashkenazi-Jew- 
ish, Chinese, and Vietnamese. The observed gene frequen- 
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C  allele  frequency in this  analysis of 234 X-chromosomes 
from widely  diverse  ethnic  subjects  is  comparable  to  that 
found by two  other laboratories  that analyzed 208  and 36 
X-chromosomes, respectively (3,  17). 
Reproducibility and Relative Sensitivity  of the  G6PD Allele 
Measurement.  To estimate the reproducibility of the assay 
for G6PD  allelic  usage,  five aliquots  of reticulocyte RNA 
from a  heterozygous female  were  processed separately  for 
first-strand  cDNA synthesis,  PCP,. amplified,  and the  ratio 
of G6PD allelic transcripts revealed by measurement of the 
LDR products by autoradiographic densitometry.  The five 
independent measurements yielded a mean of 72.16% with 
a 2.06% SD of  measurement error, thus indicating excellent 
reproducibility of this LD1L assay. 
When genomic DNA from 10 females heterozygous for 
the  G6PD  exon  11  C/T  polymorphism was  analyzed by 
the  LDP.,  assay,  a  minor  bias  of genomic  DNA  was  de- 
tected in favor of the C  allele: 54.9% with an SD of 2.4%. 
G-6-PD  Allelic  Usage by  Different  Types  of Blood Cells. 
49  female  volunteers  were  screened  for heterozygosity of 
G6PD  alleles.  The  heterozygous  state  was  found  in  10 
healthy individuals,  who volunteered for further study. For 
each  of these  heterozygous females,  remarkably consistent 
C/T  ratios were observed in preparations of their reticulo- 
cytes, platelets,  granulocytes, and PBMC  (Fig.  1 and Table 
1).  Blood mononuclear cells from five of the healthy sub- 
jects were further purified into monocytes, B,  T,  and NK 
lymphocyte  preparations,  the  transcript  C/T  ratios  of 
which closely paralleled those observed for the myeloid cell 
lineages (Table 1, individuals 2, 6, 7, 8, 10). Notably, how- 
ever, the fixed ratio for the different blood cell types in an 
individual  varied  widely  between  the  different  heterozy- 
gous  individuals.  The  ratios  of C  and  T  allelic  transcripts 
ranged  from 2.2:7.8  to  8.5:1.5  or from 21  to  87%,  when 
expressed as proportion of C  allele (Table  1). 
Evaluation of the Relative Stability in G6PD Allelic Distribu- 
tion among Hematopoietic Cells.  The  C/T  transcript  ratios 
in  different  myeloid  and lymphoid cells  were  determined 
for two  to  six  of the  heterozygous subjects  (based  on the 
subjects'  availability)  at  0,  180,  360,  580,  and  912  d.  The 
analyses performed over the first 360 d  (Table 2) indicated 
the stability of the C/T transcript ratios throughout this pe- 
riod of observation. Changes in the C/T  ratio at the differ- 
ent follow-up times were also tested separately for each cell 
type, and none was found to be significant at the 0.05 level 
in a two-sided signed rank test (15). Analyses encompassing 
the  entire  912-d  span  (with  additional  timepoints  of 580 
Figure 1.  Ligase  detection analysis of circulating blood cells. Ligase de- 
tection analysis of reverse transcribed total cellular 1KNA from reticulo- 
cytes (R), platelets (P), granulocytes  (G), monocytes (Mo),  B lymphocytes 
(B), T lymphocytes (7), NK cells (NK) in individual 8. The 46-bp prod- 
uct corresponds to T allele and the 44-bp product to C allele. 
Table  1.  The ratio of G6PD Allelic Transcripts Is Relatively 
Invariant  for Different Blood Cell Types in a Healthy Heterozygous 
Female, But Is Highly Variable between Individuals 
Hetero-  Blood cell types* 
zygous 
females  R.  P  G  M  Mo  B  T  NK 
1  49  44  51  53 
•  •  •  • 
2  59  51  52  59  58  64  59  62 
•  •  •  • 
3  84  84  84  84 
•  •  •  • 
4  76  78  78  78 
•  •  •  • 
5  66  73  75  75 
•  •  •  • 
6  85  84  85  84  87  85  81  80 
•  •  •  • 
7  61  68  70  70  66  70  72  76 
8  54  60  56  57  57  60  58  54 
9  21  21  30  29 
10  72  68  71  68  68  71  67  71 
*The cells isolated for transcript analysis as described in Materials and 
Methods,  were:  1K,  reticulocytes; P,  platelets; G,  granulocytes; M, 
mononuclear cells; Mo, monocytes; B, B lymphocytes; T, T lympho- 
cytes; NK, NK cells. Data expressed as percentage of the C allele usage 
+  standard error of  values obtained at three different time intervals (see 
Table 2). Monocytes and lymphocytes of subjects 2 and 6 and all of  the 
cells from subjects 7-10 were analyzed only on one occasion. 
and  912  d)  used  different  PC1K  equipment  and  a  slightly 
different  program  (see  Materials  and  Methods),  and  these 
results are shown in Table 2, in parentheses. 
The  data indicate  remarkable  stability of the  C/T  ratios 
in the myeloid cell lineages,  reticulocytes, platelets,  granu- 
locytes, and monocytes, for the entire 912-d of follow-up. 
To  determine  whether  the  constancy  of the  C/T  ratios 
holds true for lymphoid cells also, we used immunofluores- 
cence cell sorting to separate mononuclear cell preparations 
from individuals  2  and  6  into  pure  monocyte,  B,  T,  and 
NK  cell fractions  (Table  1,  and Figs.  1  and 2).  The  same 
C/T  ratio  was  observed  among  all  lymphoid  types  and 
monocytes and  these  ratios  were  constant  at  550  d  when 
compared to  day 0  (Fig.  2).  The  C/T  transcript  ratios  in 
lymphoid  cells  were  found  to  parallel  those  observed  for 
myeloid cells. 
Estimation of the Hemopoietic Stem Cell Number at the Time 
of X-Chromosome  Inactivation.  Based  on  the  differences 
observed  in  the  ratio  of the  X-chromosome  C/T  allelic 
transcripts  among normal heterozygous females,  the num- 
ber of the  progenitor  cells  at the  time  of X-chromosome 
inactivation would intuitively appear to be relatively small, 
since a large number of stem cells  would result in the pres- 
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Blood Cells of Heterozygous Females (C/T) 
Hetero- 
zygous 
females 
Blood cell types 
Day  R  P  G  M 
1  0  5l  (48)  45  (39)  48  47 
180  44 (45)  46 (49)  55  54 
360  52 (34)  42  (39)  49  57 
580  (38)  (41) 
2  0  63  52  (45)  55 (49)  58 
180  62  50 (43)  52  (48)  55 
360  52  50 (42)  50 (46)  63 
580  (43)  (44) 
912  (47)  (41) 
3  0  87  (76)  85  (76)  86  87 
180  86 (76)  87 (76)  85  85 
360  80 (78)  81  (79)  82  80 
580  (76)  (80) 
4  0  77  80  80  76 
180  76  78  78  78 
360  74  76  76  80 
5  0  69  71  73  75 
180  67  73  76  76 
360  63  75  76  74 
6  0  85 (72)  84 (74)  84 (84)  83 
180  85  (76)  84 (75)  85  85 
360  (70)  (72)  85  85 
580  (70)  (72) 
912  (71)  (83) 
The ratio  of G6PD allelic transcripts in blood cells remains  constant  in 
beterozygous individuals  over 360-, 580-, and 912-d intervals. 
The numbers represent  G6PD allelic transcripts expressed as percentage 
of the C allele. Stability of the C/T transcript  ratios throughout 360-d 
period of observation was observed,  on the basis of insignificant  differ- 
ences between individual  timepoints:  the two-sided P value for the in- 
erval of 180 vs 0 d is 0.875,  that for 360 vs 0 d is 0.25,  that for 360 vs 
180 d is 0.125.  Numbers in parentheses  represent  analysis performed at 
580 d and 912 d, using different  PCR conditions.  Fresh cells were used 
as a starting  material  at these  days, while stored  aliquots  of P,  NA were 
used  on days 0,  180, and  360.  The individuals  were chosen  based  on 
their availability. 
ence of equal proportions  of both allelic transcripts  (assum- 
ing  a  random  mode  of X-chromosome  inactivation).  On 
the  other  hand,  if only  a  very small  number  of stem  cells 
existed, such as two or three,  one would frequently observe 
a  single allelic transcript  due  to  the chance  selection of the 
same allele by a limited number  of stem ceils.  Our  data  ar- 
gue  against  either  of these  extremes.  When  calculations 
were performed using the mathematical model described in 
Materials  and  Methods,  the  number  of  pluripotent  he- 
mopoietic  stern  cells  present  in  the  female  embryo  at  the 
time  of X-chromosome  inactivation  was  estimated  to  be 
Figure 2.  Stability ofG6PD C/T allelic ratios in mononuclear cells. Li- 
gase  detection  analysis of reverse-transcribed  total  cellular  P,  NA  from 
monocytes  (M0), B lymphocytes  (B), T lymphocytes  (7),  NK cells (NK) 
in two individuals at days 0 and 550  (subjects 2 and 6). The day 0 C/T 
allelic ratios (C%) for individual 2 (top) were 49, 50, 51, and 51  for Mo, 
B, T, and NK cells, and 50, 55, 49, and 51, respectively, for day 550. The 
day 0 C/T ratios (C%) for individual  6 (bottom) were 69, 68, 72, and 70 
for Mo,  B,  T,  and  NK cells, and  76,  77,  73,  and  72,  respectively,  for 
day 550. 
between seven and  eight  (80% confidence interval for 3  to 
14 ceils and a 90% confidence interval for 2  to  16 cells). 
The probability of all seven or eight stem cells expressing 
a  single allele  (resulting in  "pseudoclonality")  is 0.0078,  as 
calculated  by  a  standard  formula  of binomial  probability 
(13).  In studies  of 200  samples  of apparently  nonclonal  tis- 
sues  taken  from heterozygous  females we  did not encoun- 
ter such an event. 
Statistical Evaluation  of Data Assuming Balanced Amplification 
of Stem  Cells after X-Chromosomal Inactivation.  The  above 
data indicate constancy of the allelic ratio over an extended 
Table 3.  Mathematical Model of Functional Stem  Cells Needed to 
Maintain  Constancy of the G6PD Allelic Ratio  in Blood Cells 
Percentage of  Probability of 
Total number  functioning stem cells at  achieving G6PD allelic 
of'stem cells  any one point in time  constancy 
8  100.0  1.000 
14  95.0  1.000 
28  95.0  1.000 
56  90.0  0.977 
112  77.5  0.957 
224  62.5  0.962 
448  47.5  0.953 
896  30.0  0.951 
1792  17.5  0.954 
3584  12.5  0.977 
7168  5.5  0.957 
14336  3.0  0.965 
28672  1.5  0.963 
57344  1.0  0.985 
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plained by alternative interpretations.  First,  all of the stem 
cells  could  contribute  continuously  to  the  process of he- 
matopoiesis.  Second,  an extensive, balanced amphfication 
of the original stem cell pool could occur so that the large 
size of this pool would obscure the fact that only a minor 
portion  of the  stern  cells  are actively engaged in hemato- 
poiesis at any given time. For the latter possibility to fit our 
data additional assumptions need to be made: (a) All of the 
original stem cells  would  need to divide and none  of the 
derivative subclones could gain prohferative or survival ad- 
vantage.  (b)  The  final  number  of functional  stem  cells 
would need to be relatively large. Table 3 provides a math- 
ematical evaluation of the stem cell pool sizes  required to 
maintain constancy of the  G6PD allelic  usage ratio in the 
myeloid and lymphoid cell progeny. For each given num- 
ber of stem cells (that is, the size of the stem cell pool in ex- 
istence), one can use the hypergeometric distribution table 
(12)  to estimate the percentage of stem cells that must give 
rise to the differentiated progeny to maintain a high proba- 
bility ofG6PD allehc constancy in all of the different blood 
cell lineages. For example, contribution of 30% of 896 stem 
cells  to  hematopoietic  division  and  differentiation  would 
result in a high probability (0.951)  of relative stability in the 
C  and T  allelic  ratio over many stem cell divisions.  For a 
very low percentage of stem cells,  1% for example, to func- 
tion at a given time and still maintain constant usage of the 
two X-chromosomal alleles,  the total stem cell pool would 
need to  contain  ~60,000  pluripotent stem cells.  Calcula- 
tion of the values of the probabilities appearing in Table 3 
is based on the condition of balanced usage of the X-chro- 
mosome alleles,  but these values tend to be conserved even 
when the allelic  ratio is skewed. 
Discussion 
The results of this  transcriptional analysis  of the  G6PD 
allele usage confirm that the ratio of the X-chromosome- 
derived  allelic  transcripts  varies  between  different  tissues 
and  for  different  heterozygous  females  (5,  6,  18-21).  In 
contrast,  we find that this  allehc  ratio is remarkably con- 
stant for all of the myeloid and lymphoid (T, B, and NK) 
cell  lineages  within  a  normal  heterozygous  individual. 
These data provide support for the principle that myeloid 
lineages are derived from the same hematopoietic progeni- 
tor that contributes to the lymphoid lineages in humans (9, 
22-24),  a concept that has been verified by direct labehng 
of individual stem cells by retroviral insertion (25). 
Validity of the Ligase Detection Assay for Monitoring Altelic 
Transcriptional Ratios.  Somatic  selection  has  been  impli- 
cated in studies of the distribution of G6PD-deficient cells 
in  Sardinian  females  (26)  and  apparent  selection  against 
G6PD-deficient cells has also been observed in aging South 
African  females  (27).  These  observations  were  based  on 
studies  of G6PD polymorphism that resulted in abnormal 
peptide properties, while the polymorphism that we have 
studied here is translationally silent and cannot be discerned 
at the protein level. 
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The transcriptional analysis  of G6PD alleles  used in the 
present studies has several attractive features for studies in 
humans under normal and disease-related conditions.  Our 
data confirm that normal females of all ethnic groups can be 
informative; the thermostable ligase technique  is sensitive, 
reproducible, and quantitative;  and the method allows the 
analysis of transcripts in nonnucleated cells such as reticulo- 
cytes and platelets.  In contrast to strategies employing cell 
culture  of individual  hematopoietic  colonies  (28),  this  li- 
gase detection assay can be used to assess the stem cell con- 
tribution to all aspects of hematopoiesis by individual anal- 
yses of reticulocyte, platelet, granulocyte, monocyte, B, T, 
and NK cell progeny. In addition,  any isolatable subpopu- 
lation of the different lineages can be compared by this sen- 
sitive assay. 
The current studies of normal hematopoiesis, unperturbed 
by extraneous  stimuh,  also  have an  advantage over mea- 
surements  of G6PD  isoenzymes  (28)  in  that  these  values 
may be influenced by factors such as a variable half-life of 
G6PD isoenzymes (29) and by differences in the processing 
of RNA transcripts of G6PD protein in various tissues  (30). 
Estimation of the Stem Cell Pool Size.  Our data and that 
of Puck et al.  (21)  indicate significant variation in the bal- 
ance of X-chromosome inactivation (31, 32) among meso- 
dermal ancestors of the hematopoietic stem cells in normal 
individuals. Skewing of the ratios of X-chromosome alleles 
thus  cannot  be  used  as  evidence  of oligoclonality  as  has 
been suggested (33).  This conclusion is also supported by 
studies  of HPRT  and  PGK  genomic  polymorphisms  in 
normal females (34). 
Mathematical analysis of the ratios observed for the tran- 
scripts of the G6PD alleles allowed us to estimate the num- 
ber of hematopoietic stem cell founders derived from the 
original  embryonic cells  that  randomly undergo  X-chro- 
mosome inactivation. Based on the variability of the allelic 
ratio in  10 healthy females heterozygous for this polymor- 
phism,  it can be estimated that seven or eight pluripotent 
hematopoietic stem cells may exist in female embryos near 
the time of X-chromosome inactivation during the blasto- 
cyst developmental stage (18-20). An earlier estimate of 19 
hematopoietic progenitors  at the  time of X-chromosome 
inactivation (20)  was based on an assay that could not de- 
tect  the  full  extent  of normal  skewing  of the  ratios  of 
G6PD  alleles  (5,  6,  21,  29,  30).  Our  estimate is  in  close 
agreement with that of Puck et al.  (21),  who examined the 
expression  of another  X-chromosome-encoded  enzyme, 
HPRT, in hybrid cell clones of human T  lymphocytes and 
hamster  fibroblasts  to  estimate  that  ~10  hematopoietic 
stem cells are present at the time of X-chromosome inacti- 
vation.  While  these  estimates  in  humans  contrast  with 
those  obtained  in  repopulation  studies  of irradiated  mice 
suggesting that one or two stem cells may account for all of 
the mature hemopoietic cells (25),  they are congruent with 
the  results of human bone marrow transplantation  studies 
(35).  This could indicate a species difference, but it is more 
likely that the murine bone marrow transplantation model 
does  not  accurately  reflect  the  conditions  of normal  he- 
matopoiesis. Stability  of  G6PD  Allele  Usage by  Blood Cell  Lineages. 
Remarkable  stabihty  of the  G6PD  allele  usage  was  ob- 
served  in  normal  heterozygous  females  over a  two  and  a 
half year  interval.  These  observations  in  healthy  women 
differ from those made previously in irradiated mice trans- 
planted with hematopoietic  stem cells,  marked by a retro- 
viral  transfection  marker  (25)  or  a  recognizable  chromo- 
somal feature  (36),  and  in  bone  marrow-transplanted  cats 
(28).  In these  experimental models,  significant  subsequent 
fluctuations  of G6PD  isoenzymes were seen in blood cells 
over time.  There  could be several reasons why  the  direct 
extrapolation of these findings in animal models may not be 
valid in humans.  Despite usefulness for tracing the potenti- 
ahty of a given hematopoietic precursor (25), manipulations 
of bone marrow progenitors by retroviral transfection, bone 
marrow  transplantation,  or  chemotherapy,  could  disturb 
the homeostatic  mechanisms  governing hematopoiesis  and 
thus unreliably reflect normal steady state hematopoiesis. 
The  identical  allelic  ratio  observed  in  the  short-lived 
myeloid cells, long-lived B  lymphocytes, and even longer- 
lived  T  lymphocytes,  suggests  long-term  stability  of the 
pattern of X-chromosomal allelic transcript usage in healthy 
females. Nevertheless, the data do not exclude the possibil- 
ity ofclonal succession. Indeed, data in mice indicate that a 
significant  portion  or  even  a  majority  of pluripotent  stem 
cells may be in G o phase at any given point in time (37).  It 
is  theoretically  possible  that  after  the  initial  X-chromo- 
somal inactivation in the female embryo, the initial pool of 
approximately  eight  self-renewing  hemopoietic  stem  cells 
is markedly and evenly amplified.  Given the generation  of 
a  sufficiently  large pool,  a  minority  of the  stem  cells  (but 
still a significant number)  could be actively engaged in he- 
matopoiesis,  while  the  others  remain  dormant  without 
changing  the  allelic  balance.  This  theoretical  possibility 
would  require  that  the  founder  stern  cells  undergo  many 
nondifferentiating  cell divisions after X-chromosomal inac- 
tivation and that none  of the subclones would  gain prohf- 
erative  or  survival  advantage;  i.e.,  that  clonal  selection  of 
stem cells does not take place normally. Under this scenario 
(mathematically  modeled  according  to  a  hypergeometric 
distribution  in Table 3),  the  percentage  of cells expressing 
one  allele  could  remain  unchanged  even with  the  occur- 
rence of clonal succession given the activity of a significant 
number of stem cells at any one time. 
The  observation  of the  same X-chromosome  transcrip- 
tional  ratio  in T  cells and  other types of circulating  blood 
cells suggests that the  thymus is populated by a number of 
precursor cells that is sufficiently large as not to distort the 
C/T  ratio present in the original stem cell pool. Our obser- 
vations further indicate  that the  clonal expansion  of T  and 
B  lymphocytes selected by routine antigenic stimulation  in 
the peripheral lymphoid tissues does not significantly affect 
this ratio. This picture is quite distinct from the disease state 
patterns in which these ratios may vary for myeloid or lym- 
phoid  lineages  or  both  in  myeloproliferative  and  other 
clonal  hematopoietic  diseases,  as  well  as  in  certain  infec- 
tious  and  rheumatoid  disorders  (5,  7,  22,  and  our unpub- 
lished  results).  Thus,  temporal  analysis  of  the  ratio  of 
X-chromosome--derived blood lineage cells in an informa- 
tive female allow monitoring  of clonal and oligoclonal  ex- 
pansion or contraction  that may transiently or permanently 
distort the clonal balance. 
In conclusion,  we have verified the  reproducibility  and 
quantitative  analytical potential of a transcriptional  assay of 
the  active X-chromosome  in  G6PD  heterozygous  females 
(5,  6)  and  used  it  to  evaluate  stem cell  input  into  normal 
myelopoiesis and lymphopoiesis.  The data showing consis- 
tency of a fixed pattern  of X-chromosomal usage by all of 
the  lymphoid  and  myeloid  cell  lineages  in  a  normal indi- 
vidual indicate that this analysis can be used to detect aber- 
rations in stem cell differentiation after hematopoietic  stem 
cell  transplantation  and  in  a  variety  of inherited  and  ac- 
quired gene defects that can affect the clonal distribution  of 
hematopoiesis. 
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